RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $708

Benzinga · 3d ago
RBC Capital analyst Lisa Walter maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target from $677 to $708.